指南与共识呼吸衰竭与机械通气消化、代谢与肾脏急症

我们是否错失了通过AECOPD出院小结传播GOLD建议的机会?

Are We Missing the Opportunity to Disseminate GOLD Recommendations Through AECOPD Discharge Letters?
指南 / 共识 · Int J Chron Obstruct Pulmon Dis · 2023-05-26
一句话结论克罗地亚AECOPD出院小结对GOLD建议依从性差,多数未记录ABCD分级和肺功能严重度,专科层面依从性亟待提高。

该研究分析了克罗地亚疫情前因AECOPD就诊于急诊科的患者的出院小结(DL),按临床决策分为住院出院小结(HDL,n=225)和急诊离院门诊治疗出院小结(ERDL,n=368),由经验丰富的呼吸科医生通过在线研究专用问卷对照GOLD指南核查。结果显示,多数DL未包含GOLD ABCD分级(HDL 85%、ERDL 92%)或基于肺功能的严重度分级(HDL 90%、ERDL 91%);AE表型见于三分之二HDL和三分之一ERDL;既往维持治疗调整(多为升级)分别推荐于58.4% HDL和27.9% ERDL;吸入器正确使用教育仅推荐于15.6% HDL;戒烟措施分别建议于23.1% HDL和7.9% ERDL,肺康复分别建议于35.6% HDL和0.8% ERDL;早期随访常被建议(>50%)但很少被预约。结论认为对GOLD指南的依从性存在显著缺陷,错失了让全科医生了解GOLD建议的机会,强调首先在专科层面提高指南依从性并实现DL标准化。

要点

  • 多数AECOPD出院小结未记录GOLD ABCD分级(HDL 85%、ERDL 92%)或肺功能严重度分级(HDL 90%、ERDL 91%)。
  • 既往维持治疗调整(多为升级)推荐于58.4% HDL和27.9% ERDL;吸入器正确使用教育仅推荐于15.6% HDL。
  • 戒烟措施建议于23.1% HDL和7.9% ERDL;肺康复建议于35.6% HDL和0.8% ERDL。
  • 早期随访常被建议(>50%)但很少被预约;AE表型见于三分之二HDL和三分之一ERDL。
  • 血嗜酸性粒细胞计数常可获得,但未被作为决策相关信息考虑。

适用人群与场景

  • 疫情前因AECOPD到急诊科就诊的患者,按临床决策分为住院(HDL)和急诊离院门诊治疗(ERDL)两组。

研究设计与关键结果

  • 研究类型为对疫情前AECOPD急诊就诊患者出院小结的核查分析,共分析225份HDL和368份ERDL,由经验丰富的呼吸科医生通过在线研究专用问卷对照GOLD指南核查。
  • 多数出院小结未包含GOLD ABCD分级(HDL 85%、ERDL 92%)或基于肺功能的严重度分级(HDL 90%、ERDL 91%)。
  • 既往一年AE次数有记录,但未明确写出具体频繁急性加重表型;AE表型见于三分之二HDL和三分之一ERDL。
  • 血嗜酸性粒细胞计数常可获得,但未被作为决策相关信息考虑。
  • 既往维持治疗调整(多为升级)推荐于58.4% HDL和27.9% ERDL;吸入器正确使用教育仅推荐于15.6% HDL。
  • 戒烟措施建议于23.1% HDL和7.9% ERDL;肺康复建议于35.6% HDL和0.8% ERDL。
  • 早期随访常被建议(>50%),但很少被预约。

证据类型、等级与局限

  • 证据类型:指南依从性核查研究(基于在线研究专用问卷的出院小结分析)。
  • 局限:原文未报告局限性。

对床旁实践的改变

  • 作者认为,研究结果强调有必要首先在专科层面提高对指南的依从性,并随之实现出院小结的标准化,以减少全科医生了解GOLD建议的机会缺失。

指南或共识出处

  • GOLD(慢性阻塞性肺疾病全球倡议)建议。

提炼说明

  • 本条依据论文摘要整理;摘要未涉及「诊断标准与关键阈值」「处置流程与药物剂量」「红旗征与不能漏的情况」,故未列出这些栏目;全文请点「阅读原文」。
英文原文(摘要)· 点击展开

INTRODUCTION: Acute exacerbations in chronic obstructive pulmonary disease (AECOPD) lead to poor outcomes and increased burden for patients and healthcare systems. The Global Initiative for COPD (GOLD) includes specific recommendations for AECOPD interventions, discharge criteria, and follow-up. Aligning the AECOPD discharge letters (DL) with GOLD guidelines could facilitate dissemination of recommendations among general practitioners (GPs).

PURPOSE: This study was conducted to assess the compliance of DL with the GOLD recommendations in Croatia.

METHODS: Pre-pandemic DL of patients presenting for AECOPD to emergency room (ER) were analyzed and stratified by clinical decision to hospitalize (HDL) or discharge patients for outpatient treatment (ERDL). Experienced pulmonologists checked the information from DL against guidelines by using online study-specific questionnaires.

RESULTS: In total, 225 HDL and 368 ERDL were analyzed. In most cases, the GOLD ABCD categories (85% HDL, 92% ERDL) or the spirometry-based degree of severity (90% HDL, 91% ERDL) were not included. The number of AEs in the previous year was recorded, but the specific frequent exacerbator phenotype not explicitly stated. The AE phenotype was included in two thirds of HDL and one third of ERDL. The blood eosinophil count was frequently available, but not considered decision-relevant information. Adjustments of previous maintenance therapy, mostly escalation, were recommended in 58.4% HDL and 27.9% ERDL, respectively. Education on proper use of inhalers was recommended only in 15.6% of HDL. Smoking cessation measures were advised in 23.1% HDL and 7.9% ERDL; pulmonary rehabilitation in 35.6% HDL and 0.8% ERDL. Early follow-up was frequently advised (>50%), but rarely appointed.

CONCLUSION: Significant deficiencies in compliance with the GOLD guidelines were identified, translating into a missed opportunity for GPs to become acquainted with GOLD recommendations. These findings emphasize the necessity to increase compliance with guidelines first at specialist level and consequent standardization of DL.

来源:Int J Chron Obstruct Pulmon Dis,查看原文。版权归原作者所有。

参考来源

  1. Vukić Dugac A, Vergles M, Škrinjarić Cincar S, et al. Are We Missing the Opportunity to Disseminate GOLD Recommendations Through AECOPD Discharge Letters? Int J Chron Obstruct Pulmon Dis. 2023. PMID: 37260546. doi:10.2147/COPD.S408307

供执业医师抢救与诊疗参考,不替代临床判断;剂量请结合体重、肝肾功能和本院药品规格复核,以指南原文为准。